Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
GBS Software AG: A reportable insider transaction was published on 18th July 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 18th July 2025,
The Insider Transaction was made by Hertzsch, Frank 
. The transaction toke place on 15th July 2025. The order was executed at the trading place Xetra. . The aggregated volume was 5.299,32 EUR, based on an average price of 3,16 EUR. The nature of the Investment was Sell.
PATRIZIA SE: A reportable insider transaction was published on 17th June 2025. The reporting obligation was triggered by a person related to Other executive.
Transaction reporting date: 17th June 2025,
The Insider Transaction was made by Kuhnke, Frank . The transaction toke place on 16th June 2025. . The aggregated volume was 385.505,41 EUR, based on an average price of 8,19 EUR. The nature of the Investment was Buy.
PATRIZIA SE: A reportable insider transaction was published on 17th June 2025. The reporting obligation was triggered by a person related to Other executive.
Transaction reporting date: 17th June 2025,
The Insider Transaction was made by Kuhnke, Frank . The transaction toke place on 13th June 2025. . The aggregated volume was 217.547,03 EUR, based on an average price of 7,79 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 6th June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th June 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 6th June 2025. . The aggregated volume was 1.000.000,00 EUR, based on an average price of 4,00 EUR. The nature of the Investment was Sell.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 2nd June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 2nd June 2025,
The Insider Transaction was made by Weber, Frank . The transaction toke place on 30th May 2025. . The aggregated volume was 218.499,86 EUR, based on an average price of 78,60 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 23rd April 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 23rd April 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 17th April 2025. . The aggregated volume was 440.000,00 EUR, based on an average price of 4,40 EUR. The nature of the Investment was Sell.
SAF-HOLLAND SE: A reportable insider transaction was published on 8th April 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 8th April 2025,
The Insider Transaction was made by Lorenz-Dietz, Frank . The transaction toke place on 7th April 2025. The order was executed at the trading place Xetra. . The aggregated volume was 16.362,50 EUR, based on an average price of 12,50 EUR. The nature of the Investment was Buy.
Schaeffler AG: A reportable insider transaction was published on 31st March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 31st March 2025,
The Insider Transaction was made by Wagner, Uwe . The transaction toke place on 28th March 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 40.092,20 EUR, based on an average price of 4,01 EUR. The nature of the Investment was Buy.
Schaeffler AG: A reportable insider transaction was published on 13th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th March 2025,
The Insider Transaction was made by Wagner, Uwe . The transaction toke place on 12th March 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 100.314,80 EUR, based on an average price of 4,18 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 12th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 12th March 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 10th March 2025. The order was executed at the trading place Xetra. . The aggregated volume was 16.920,00 EUR, based on an average price of 1,88 EUR. The nature of the Investment was Buy.
Syzygy AG: A reportable insider transaction was published on 25th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 25th February 2025,
The Insider Transaction was made by Wolfram, Frank . The transaction toke place on 24th February 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 26.400,00 EUR, based on an average price of 2,64 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.